$130.17 3.78 (2.82%)
7:21 EST ZTS Stock Quote Delayed 15 Minutes
Previous Close $133.95
Market Cap 62.98B
PE Ratio 65.41
Volume (Avg. Vol.) 3,797
Day's Range 133.95 - 133.95
52-Week Range 91.21 - 146.26
Dividend & Yield 0.38 (0.29%)
ZTS Stock Predictions, Articles, and Zoetis News
- From InvestorPlace
- From the Web
The grades of 4 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Why Marathon Oil Corporation (MRO), Viacom, Inc. (VIAB) and Zoetis Inc (ZTS) Are 3 of Today’s Worst Stocks
Marathon Oil (MRO), Viacom (VIAB) and Zoetis Inc (ZTS) couldn't shrug off a wave of bad news on the first trading day of this week.
Investors and analysts are raising their eyebrows over some strange goings on at Valeant Pharmaceuticals, leading to our bear call on VRX stock
During these times, it pays to stay on top of the latest profit opportunities. Today's post is a great place to start with updated rankings for 60 stocks
During these times it pays to stay on top of the latest profit opportunities. Today's blog post should be a great place to start with these 73 stock trades
In this low interest rate environment, dividends are still looking great. Here is a list of 44 dividend stocks set for payouts this quarter
Among the leading companies moving to make shareholders happy last week was a mega-cap biotechnology giant, a mammoth defense and aerospace contractor, the biggest drug retailer in the world and a Big Pharma behemoth.
During these busy times, it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start.
Zoetis is a dominant market leader with decided scale advantages over its peers, operating in an industry with clear macro tailwinds. ZTS stock is a good buy at this level.
I want to clue you in on one of the equities I have a position in my Trader's Advantage service.
This week, nine pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Dividend stocks in just about every sector thrilled investors with meaningful payout raises in Q4. Here's a look at 45 of the biggest blue chips to up the ante.
The central bank’s “patience” stance when it comes to future interest rate hikes was a present to the bulls, and the result was a week of pre-holiday stock market revelry. Here are 13 stocks increasing dividends.
From The Motley Fool
From Seeking Alpha
From Market News Video
From Analyst Ratings
Yesterday, the CEO of Zoetis (ZTS – Research Report), Kristin Peck, sold shares of ZTS for $1.65M. Following Kristin Peck’s last ZTS Sell transaction on November 14, 2019, the stock climbed by 20.1%. In addition to Kristin Peck, 4 other ZTS executives reported Sell trades in the last month. See today’s analyst top recommended stocks
Navellier RatingsPowered by Portfolio Grader